RUTH FISHER: Open Payments
NPI 1104584366 · GOSHEN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 28 payments from 18 companies in 2025. Trend: 2023 $361 · 2024 $659 · 2025 $681
Food & beverage: $681
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $136 |
| Vanda Pharmaceuticals Inc. | 3 | $111 |
| Axsome Therapeutics, Inc. | 1 | $100 |
| Edwards Lifesciences Corporation | 1 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Indivior Inc. | 2 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| Verona Pharma, Inc. | 1 | $25 |
| IBSA Pharma Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
Products named: FANAPT, Symbravo, VRAYLAR, UBRELVY, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), CAPLYTA, SUBLOCADE, SPRAVATO.
Industry payments across IN — which companies pay providers there.
